Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA approves Lilly-backed Bluetooth insulin device

Clears Companion Medical’s Bluetooth-enabled pen and smartphone app

Digital pharmaUS regulators have cleared a Bluetooth-enabled insulin pen and associated smartphone app from Companion Medical.

The San Diego-based medical device firm last year received funding from Lilly, with the pharma company gaining a seat on Companion's board. The FDA approved Companion's InPen system for use with Lilly's Humalog or Novo Nordisk's Novolog rapid acting insulins and also passed its InPen app for Apple iOS.

The company plans to release an Android version later this year and has also filed for a CE Mark (kitemark) in Europe.

Sean Saint, Companion Medical's chief executive officer, said: "FDA clearance of the InPen and mobile app represents a significant advancement in diabetes care.

"The product combines the benefits of sophisticated insulin pumps with the simplicity and affordability of pens and syringes, providing patients, physicians, and caregivers increased confidence that diabetes is being managed optimally."

23rd August 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics